Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Filer

Showing results (121-130 of 161) with videos related to

Pageof 17
Sort By:
Annals of the Rheumatic Diseases|August 9, 2011
Delays in assessment of patients with rheumatoid arthritis: variations across EuropeKarim Raza, Rebecca Stack, Kanta Kumar, et al.
Science Advances|December 8, 2021
Inflammation causes remodeling of mitochondrial cytochrome <i>c</i> oxidase mediated by the bifunctional gene <i>C15orf48</i>Sally A Clayton, Kalbinder K Daley, Lucy MacDonald, et al.
Nature Communications|September 22, 2020
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritisFrank Penkava, Martin Del Castillo Velasco-Herrera, Matthew D Young, et al.
Nature Communications|January 3, 2025
Molecular and spatial analysis of tertiary lymphoid structures in Sjogren's syndromeSaba Nayar, Jason D Turner, Saba Asam, et al.
Annals of the Rheumatic Diseases|February 25, 2022
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatologyAurélie Najm, Félicie Costantino, Stefano Alivernini, et al.
Plos One|July 11, 2013
Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in europeansJoanna E Cobb, Darren Plant, Edward Flynn, et al.
Lancet (London, England)|February 16, 2024
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trialAndrew P Cope, Marianna Jasenecova, Joana C Vasconcelos, et al.
Nature|December 13, 2025
Author Correction: Distinct fibroblast subsets drive inflammation and damage in arthritisAdam P Croft, Joana Campos, Kathrin Jansen, et al.
BMC Rheumatology|July 19, 2021
BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort studyFiona Rayner, Amy E Anderson, Kenneth F Baker, et al.
Nature Communications|August 29, 2024
Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissueRichard D Bell, Matthew Brendel, Maxwell A Konnaris, et al.
Pageof 17

Showing results (121-130 of 161) with videos related to

Sort By:
Pageof 17
Annals of the Rheumatic Diseases|August 9, 2011
Delays in assessment of patients with rheumatoid arthritis: variations across EuropeKarim Raza, Rebecca Stack, Kanta Kumar, et al.
Science Advances|December 8, 2021
Inflammation causes remodeling of mitochondrial cytochrome <i>c</i> oxidase mediated by the bifunctional gene <i>C15orf48</i>Sally A Clayton, Kalbinder K Daley, Lucy MacDonald, et al.
Nature Communications|September 22, 2020
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritisFrank Penkava, Martin Del Castillo Velasco-Herrera, Matthew D Young, et al.
Nature Communications|January 3, 2025
Molecular and spatial analysis of tertiary lymphoid structures in Sjogren's syndromeSaba Nayar, Jason D Turner, Saba Asam, et al.
Annals of the Rheumatic Diseases|February 25, 2022
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatologyAurélie Najm, Félicie Costantino, Stefano Alivernini, et al.
Plos One|July 11, 2013
Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in europeansJoanna E Cobb, Darren Plant, Edward Flynn, et al.
Lancet (London, England)|February 16, 2024
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trialAndrew P Cope, Marianna Jasenecova, Joana C Vasconcelos, et al.
Nature|December 13, 2025
Author Correction: Distinct fibroblast subsets drive inflammation and damage in arthritisAdam P Croft, Joana Campos, Kathrin Jansen, et al.
BMC Rheumatology|July 19, 2021
BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort studyFiona Rayner, Amy E Anderson, Kenneth F Baker, et al.
Nature Communications|August 29, 2024
Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissueRichard D Bell, Matthew Brendel, Maxwell A Konnaris, et al.
Pageof 17